Losses narrow at Cymra Life Sciences as CEO bemoans ‘unfair trading conditions’ by Steve Jones November 13, 2024November 14, 2024 Byron Bay-based Cymra Life Sciences halved its losses in FY24 as sales rocketed to more than […]
It’s time for the TGA to give Australian cannabis companies a fair go by Martin Lane February 10, 2021April 26, 2024
Exclusive: Department of Health considers making imported medical cannabis meet GMP standards by Rhys Cohen October 6, 2020April 26, 2024
